Ulcerative colitis: open trials in Belgium

36 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
AZORG Campus Aalst-Moorselbaan, Aalst · Université Libre de Bruxelles - Hôpital Erasme, Brussels · AZ Groeninge Campus Kennedylaan, Kortrijk · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège · Clinical Chc Montlégia, Liège
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare
Registry updated 2026-11-04
NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Trial Treatment · Phase 2 · Arena Pharmaceuticals Inc.
UZ Leuven, Leuven
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hopital Erasme, Anderlecht · Imelda, Bonheiden · Az Sint-Lucas, Brugge · Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Az Sint-Lucas, Brugge · Universitair Ziekenhuis Gent, Gent · AZ Sint-Lucas & Volkskliniek, Gent · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · Vitaz, Sint-Niklaas
Registry updated 2026-11-03
2024-511458-32-00
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Centre Hospitalier Regional de la Citadelle, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur
Registry updated 2026-10-26
NCT02421705
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
Trial Treatment · KU Leuven
University Hospitals Leuven, Leuven
Registry updated 2026-10-22
NCT06100289
Phase 3 Study of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
Trial Treatment · Phase 3 · Takeda Development Center Americas Inc.
CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-21
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Brussels · Brussels · Edegem · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège · Liège
Registry updated 2026-10-20
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn’s Disease (CD)
Trial Treatment · Phase 2 · Takeda Development Center Americas Inc.
Hopital Erasme, Anderlecht · CHU Saint-Pierre, Brussels · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège
Registry updated 2026-10-20
NCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Centre Hospitalier Regional de la Citadelle, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur
Registry updated 2026-10-20
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Yvoir
Registry updated 2026-10-16
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
UZ Brussel, Brussels · Cliniques universitaires Saint-Luc, Brussels · Antwerp University Hospital, Edegem · UZ Gent, Ghent · UZ Leuven, Leuven
Registry updated 2026-10-07
NCT06405087
Vedolizumab Subcutaneous Long-term Open-label Extension Study in Pediatric Subjects
Trial Treatment · Phase 3 · Takeda Development Center Americas Inc.
CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-01
NCT07071519
A Study to Assess the Adverse Events, Effectiveness, and How the Drug Moves through the Body of Intravenous and Subcutaneous Injections of Risankizumab in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · AbbVie Deutschland GmbH & Co. KG
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-25
NCT06581042
Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
Research · AbbVie
Universite Libre de Bruxelles - Hopital Erasme /ID# 268632, Anderlecht · Imelda Ziekenhuis /ID# 268631, Bonheiden · Ziekenhuis Oost-Limburg, Campus St.-Jan /ID# 283334, Genk · UZ Gent /ID# 268630, Ghent · AZ Groeninge /ID# 268638, Kortrijk · Groupe Sante CHC - Clinique du MontLegia /ID# 268662, Liège · CHU de Liege /ID# 267209, Liège · Chu De Charleroi - Hopital Civil Marie Curie /ID# 284063, Lodelinsart · AZ-Delta. /ID# 283323, Roeselare · Vitaz /Id# 268637, Sint-Niklaas · Centre Hospitalier De Wallonie Picarde - Site Notre Dame /ID# 284064, Tournai
Registry updated 2026-09-23
NCT04624230
OPEN LABEL, MAINTENANCE STUDY OF ORAL TOFACITINIB IN CHILDREN WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Trial Treatment · Phase 3 · Pfizer Inc.
Universitair Ziekenhuis Brussel, Brussel · Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-18
NCT05442567
A Long-term Study in Children and Teenagers with Ulcerative Colitis or Crohn’s Disease treated with Vedolizumab IV
Trial Treatment · Phase 3 · Takeda Development Center Americas Inc.
Antwerp University Hospital, Edegem · UZ Brussel, Jette · UZ Leuven, Leuven
Registry updated 2026-09-03
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics Inc.
Az Sint-Lucas, Brugge · AZ Sint-Lucas & Volkskliniek, Gent · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · Vitaz, Sint-Niklaas
Registry updated 2026-08-24
NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Trial Treatment · Phase 2 · Boehringer Ingelheim
UZ Leuven, Leuven · CHC MontLégia, Liège
Registry updated 2026-08-21
2023-503509-12-00
Model-informed precision dosing during infliximab rescue therapy for patients with steroid-refractory acute severe ulcerative colitis: an exploratory study (the IGNITE study)
Trial Treatment · Phase 4 · UZ Leuven
UZ Leuven, Leuven
Registry updated 2026-08-11
NCT05782907
Ulcerative Colitis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Abbvie Deutschland GmbH & Co. KG
Antwerp University Hospital, Edegem · UZ Leuven, Leuven
Registry updated 2026-08-05
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
UZ Leuven, Leuven
Registry updated 2026-07-31
NCT07665723
An Early-Stage Study in Multiple Clinics of how Afimkibart May Affect the Body’s Processing of Medicines that Rely on Cytochrome P450 Enzymes in Patients with Ulcerative Colitis
Trial Treatment · Phase 1 · F. Hoffmann-La Roche AG
UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare
Registry updated 2026-07-27

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error